SCM
ARIA

Stevens Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Stevens Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,728
Closed -$117K – 1245
2015
Q4 		$117K Buy
+18,728
New +$123K ﹤0.01% 845
2015
Q2 		– Sell
-13,240
Closed -$109K – 1368
2015
Q1 		$109K Buy
+13,240
New +$97.9K ﹤0.01% 920
2014
Q4 		– Sell
-11,890
Closed -$64K – 1368
2014
Q3 		$64K Sell
11,890
-19,759
-62% -$115K ﹤0.01% 954
2014
Q2 		$202K Buy
+31,649
New +$218K 0.01% 932

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Stevens Capital Management's ARIA Position: Q1 2016 in Review

Stevens Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 18,728 shares — an estimated $117K sold.

Stevens Capital Management first reported a position in ARIA in Q2 2014 and held it in 4 quarters. The position peaked at $202K in Q2 2014. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

  • Stevens Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Stevens Capital Management sold 18,728 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $117K.
  • Stevens Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and held it in 4 quarters.
  • Stevens Capital Management's Ariad Pharmaceuticals Inc position peaked at $202K in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Stevens Capital Management's 13F filing for Q1 2016, filed 13 May 2016.